Bharat Biotech’s interim efficacy is good news. Should be followed by publication of it
50-Word Edit

Bharat Biotech’s interim efficacy is good news. Should be followed by publication of it

ThePrint view on the most important issues, instantly.

   
50

ThePrint

India’s own Covaxin demonstrating 81% interim efficacy is welcome news. Although Bharat Biotech is a company of repute, this announcement by the firm should be quickly followed by publication in an independent journal. That will help end all doubts considering the controversy that had been sparked over its emergency approval.

With 75% private sector job reservation, Haryana mixing desperate politics with bad economics

Haryana’s reservation of 75 per cent private sector jobs for local workforce is a terrible direction to put the economy on, and will only embolden Noida-Greater Noida’s rise. India’s labour mobility is already low, and parochial politics mustn’t shackle industry. Haryana, like others, is mixing desperate politics with bad economics.

Adityanath calling out women’s safety in Bengal is rich. Headlines from UP say it all

UP CM Yogi Adityanath’s claim that Bengal has failed to provide security to its women, is rich. He should look in the mirror and read the headlines of horrific crimes against women in UP every other day. This can be good politics only after Adityanath addresses the problem at home.